The India Gene synthesis market is expected to reach USD 459.81 million by 2030 from USD 74.77 million in 2022, growing at a CAGR of 25.5% during the forecast period of 2023 to 2030.
Market Segmentation
India Gene Synthesis Market, By Component (Synthesizer, Consumables, and Software & Services), By Gene Type (Standard Gene, Express Gene, Complex Gene, and Others), Gene Synthesis Type (Gene Library Synthesis and Custom Gene Synthesis), Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutic Antibodies, and Others), Method (Solid Phase Synthesis, Chip Based DNA Synthesis, and PCR-Based Enzyme Synthesis). End user, (Academic & Research Institutes, Diagnostic Laboratories, Biotech & Pharmaceutical Companies, Contract Research Organizations (CRO), Agriculture, Food, and Others), Distribution Channel (Direct Tender, Online Distributions, and Third Party Distributors), Country (India) - Industry Trends and Forecast to 2030
Overview of India Gene Synthesis Market Dynamics
Drivers
• Increased prevalence of chronic infectious diseases
Restraint
• Lack of trained professionals
Opportunity
• Rise in healthcare expenditure
Market Players
Some of the major market players operating in India gene synthesis market are:
• Thermo Fisher Scientific Inc.
• Boster Biological Technology
• Twist Bioscience
• OriGene Technologies, Inc.
• Eurofins Scientific
• GenScript
• Merck KGaA
• Kaneka Eurogentec S.A
• Synbio Technologies
• GCC Biotech (INDIA) Pvt. Ltd.
TABLE OF CONTENT
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 OVERVIEW OF INDIA GENE SYNTHESIS MARKET 11
1.4 CURRENCY AND PRICING 13
1.5 LIMITATION 13
1.6 MARKETS COVERED 13
2 MARKET SEGMENTATION 15
2.1 MARKETS COVERED 15
2.2 GEOGRAPHIC SCOPE 16
2.3 YEARS CONSIDERED FOR THE STUDY 16
2.4 CURRENCY AND PRICING 16
2.5 RESEARCH METHODOLOGY 17
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20
2.7 MULTIVARIATE MODELLING 21
2.8 COMPONENT SEGMENT LIFELINE CURVE 21
2.9 Cognate Lifesciences MARKET POSITION GRID 22
2.10 MARKET APPLICATION COVERAGE GRID 24
2.11 THE CATEGORY VS TIME GRID 25
2.12 SECONDARY SOURCES 26
2.13 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 30
4.1 PESTEL 31
4.2 PORTER'S FIVE FORCES MODEL 32
4.3 MARKET POTENTIAL 33
4.4 PRICING ANALYSIS 35
5 INDIA GENE SYNTHESIS MARKET: REGULATIONS 37
6 MARKET OVERVIEW 38
6.1 DRIVERS 40
6.1.1 INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES 40
6.1.2 RISING ADOPTION OF GENE THERAPY 40
6.1.3 EXPANSION OF SYNTHETIC BIOLOGY 41
6.1.4 RISING INTEREST IN GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY 42
6.2 RESTRAINTS 42
6.2.1 LACK OF TRAINED PROFESSIONALS 42
6.2.2 ETHICAL ISSUES 43
6.3 OPPORTUNITIES 43
6.3.1 RISE IN HEALTHCARE EXPENDITURE 43
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 44
6.3.3 RISING DEMAND FOR CUSTOMIZED/PERSONALIZED MEDICATIONS 44
6.4 CHALLENGES 45
6.4.1 TECHNICAL LIMITATIONS ACROSS THE PRODUCTION PROCESS 45
6.4.2 REGULATORY FRAMEWORK 45
7 INDIA GENE SYNTHESIS MARKET, BY COMPONENT 46
7.1 OVERVIEW 47
7.2 SOFTWARE & SERVICES 50
7.3 CONSUMABLES 50
7.3.1 REAGENTS 50
7.3.2 ASSAYS 50
7.3.3 PROBES & DYES 50
7.3.4 OTHERS 50
7.4 SYNTHESIZER 51
7.4.1 COLUMN-BASED SYNTHESIZERS 51
7.4.2 MICROARRAY-BASED SYNTHESIZERS 51
8 INDIA GENE SYNTHESIS MARKET, BY GENE TYPE 52
8.1 OVERVIEW 53
8.2 STANDARD GENE 56
8.3 COMPLEX GENE 56
8.4 EXPRESS GENE 56
8.5 OTHERS 56
9 INDIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE 57
9.1 OVERVIEW 58
9.2 CUSTOM GENE SYNTHESIS 61
9.2.1 STANDARD GENE 61
9.2.2 COMPLEX GENE 61
9.2.3 EXPRESS GENE 61
9.2.4 OTHERS 61
9.3 GENE LIBRARY SYNTHESIS 62
9.3.1 STANDARD GENE 62
9.3.2 COMPLEX GENE 62
9.3.3 EXPRESS GENE 62
9.3.4 OTHERS 62
10 INDIA GENE SYNTHESIS MARKET, BY APPLICATION 63
10.1 OVERVIEW 64
10.2 SYNTHETIC BIOLOGY 67
10.2.1 CUSTOM GENE SYNTHESIS 67
10.2.2 GENE LIBRARY SYNTHESIS 67
10.3 GENETIC ENGINEERING 67
10.3.1 CUSTOM GENE SYNTHESIS 68
10.3.2 GENE LIBRARY SYNTHESIS 68
10.4 THERAPEUTIC ANTIBODIES 68
10.4.1 CUSTOM GENE SYNTHESIS 68
10.4.2 GENE LIBRARY SYNTHESIS 68
10.5 VACCINE DESIGN 69
10.5.1 CUSTOM GENE SYNTHESIS 69
10.5.2 GENE LIBRARY SYNTHESIS 69
10.6 OTHERS 69
11 INDIA GENE SYNTHESIS MARKET, BY METHOD 70
11.1 OVERVIEW 71
11.2 PCR-BASED ENZYME SYNTHESIS 74
11.3 CHIP-BASED DNA SYNTHESIS 74
11.4 SOLID BASED SYNTHESIS 74
12 INDIA GENE SYNTHESIS MARKET, BY END USER 75
12.1 OVERVIEW 76
12.2 ACADEMIC & RESEARCH INSTITUTE 79
12.3 BIOTECH & PHARMACEUTICAL COMPANIES 79
12.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 79
12.5 DIAGNOSTIC LABORATORIES 79
12.6 AGRICULTURE 79
12.7 FOOD 79
12.8 OTHERS 79
13 INDIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL 80
13.1 OVERVIEW 81
13.2 DIRECT TENDER 84
13.3 ONLINE DISTRIBUTION 84
13.4 THIRD PARTY DISTRIBUTORS 84
14 INDIA GENE SYNTHESIS MARKET: COMPANY LANDSCAPE 85
14.1 COMPANY SHARE ANALYSIS: INDIA 85
15 SWOT ANALYSIS 86
16 COMPANY PROFILE 87
16.1 THERMO FISHER SCIENTIFIC INC. 87
16.1.1 COMPANY SNAPSHOT 87
16.1.2 REVENUE ANALYSIS 87
16.1.3 PRODUCT PORTFOLIO 88
16.1.4 RECENT DEVELOPMENT 88
16.2 EUROFINS SCIENTIFIC 89
16.2.1 COMPANY SNAPSHOT 89
16.2.2 REVENUE ANALYSIS 89
16.2.3 SERVICE PORTFOLIO 90
16.2.4 RECENT DEVELOPMENT 90
16.3 MERCK KGAA 91
16.3.1 COMPANY SNAPSHOT 91
16.3.2 REVENUE ANALYSIS 91
16.3.3 PRODUCT PORTFOLIO 92
16.3.4 RECENT DEVELOPMENT 92
16.4 KANEKA EUROGENTEC S.A. 93
16.4.1 COMPANY SNAPSHOT 93
16.4.2 REVENUE ANALYSIS 93
16.4.3 PRODUCT PORTFOLIO 94
16.4.4 RECENT DEVELOPMENTS 94
16.5 BOSTER BIOLOGICAL TECHNOLOGY 95
16.5.1 COMPANY SNAPSHOT 95
16.5.2 SERVICE PORTFOLIO 95
16.5.3 RECENT DEVELOPMENT 95
16.6 GCC BIOTECH (INDIA) PVT. LTD. 96
16.6.1 COMPANY SNAPSHOT 96
16.6.2 PRODUCT PORTFOLIO 96
16.6.3 RECENT DEVELOPMENT 96
16.7 GENSCRIPT 97
16.7.1 COMPANY SNAPSHOT 97
16.7.2 REVENUE ANALYSIS 97
16.7.3 PRODUCT PORTFOLIO 98
16.7.4 RECENT DEVELOPMENTS 98
16.8 ORIGENE TECHNOLOGIES, INC 99
16.8.1 COMPANY SNAPSHOT 99
16.8.2 PRODUCT PORTFOLIO 99
16.8.3 RECENT DEVELOPMENTS 99
16.9 SYNBIO TECHNOLOGIES 100
16.9.1 COMPANY SNAPSHOT 100
16.9.2 PRODUCT PORTFOLIO 100
16.9.3 RECENT DEVELOPMENTS 100
16.10 TWIST BIOSCIENCE 101
16.10.1 COMPANY SNAPSHOT 101
16.10.2 REVENUE ANALYSIS 101
16.10.3 PRODUCT PORTFOLIO 102
16.10.4 RECENT DEVELOPMENTS 102
17 QUESTIONNAIRE 103
18 RELATED REPORTS 107
Segmentation
Short Description
India Gene Synthesis Market, By Component (Synthesizer, Consumables, and Software & Services), By Gene Type (Standard Gene, Express Gene, Complex Gene, and Others), Gene Synthesis Type (Gene Library Synthesis and Custom Gene Synthesis), Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutic Antibodies, and Others), Method (Solid Phase Synthesis, Chip Based DNA Synthesis, and PCR-Based Enzyme Synthesis). End user, (Academic & Research Institutes, Diagnostic Laboratories, Biotech & Pharmaceutical Companies, Contract Research Organizations (CRO), Agriculture, Food, and Others), Distribution Channel (Direct Tender, Online Distributions, and Third Party Distributors), Country (India) - Industry Trends and Forecast to 2030
Market Definition
Gene synthesis refers to the chemical synthesis of DNA strand base by base. Different DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for the creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
The technological progressions in gene synthesis have modernized synthetic biology research. Scientists are no longer limited to classical methods of manipulating a single gene at a time; they now have the power to design or reprogram entire genomes and cells. The newly synthesized viral genomes are expected to boost vaccine development, eliminate cancer cells and produce sustainable biofuels, in the coming future. We can detect and break down environmental pollutants in the soil, air, and water. Biotechnology and Life Science researchers and academia across many research discipline areas are accelerating the advancements in healthcare, agriculture, energy, and other fields of human endeavor, through the use of newly synthesized genomes.
Market Segmentation
India gene synthesis market is segmented into three notable segments which are on the basis of type, location, and application.
• On the basis of component, the market is segmented into synthesizer, consumables, and software & services
• On the basis of gene type, the India gene synthesis market is segmented into standard gene, express gene, complex gene, and others
• On the basis of gene synthesis type, the market is segmented into gene library synthesis and custom gene synthesis
• On the basis of application, the market is segmented into synthetic biology, genetic engineering, vaccine design, therapeutic antibodies, and others
• On the basis of method, the market is segmented into solid phase synthesis, chip-based DNA synthesis, and PCR-based enzyme synthesis
• On the basis of end-user, the market is segmented into academic & research institutes, diagnostic laboratories, biotech & pharmaceutical companies, contract research organizations (CRO), agriculture, food, and others
• On the basis of distribution channel, the market is segmented into direct tender, online distribution, and third party distributors
Market Players
Some of the major market players operating in the India gene synthesis market are:
• Thermo Fisher Scientific Inc.
• Boster Biological Technology
• Twist Bioscience
• OriGene Technologies, Inc.
• Eurofins Scientific
• GenScript
• Merck KGaA
• Kaneka Eurogentec S.A
• Synbio Technologies
• GCC Biotech (INDIA) Pvt. Ltd.
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
